Sit Investment Associates Inc Dbv Technologies S.A. Transaction History

Sit Investment Associates Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$16.81 - $24.58 $34,460 - $50,389	-2,050 Closed	0 $0
Q2 2018 Jul 19, 2018	SELL	$18.6 - $24.94 $312,480 - $418,992	-16,800 Reduced 89.12%	2,050 $40,000
Q3 2017 Oct 18, 2017	BUY	$39.62 - $46.17 $746,837 - $870,304	18,850	18,850 $800,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $792M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Sit Investment Associates Inc with notifications on news.